41 Remarkably, a previous questionnaire revealed that when asked for their preference of anti-TNF administration, patients showed a trend towards intravenous rather than subcutaneous treatment. 42 The yet unexplored question is whether patients would prefer an oral drug or a subcutaneous/intravenous injection over a longer distance, thus allowing them to forget about the disease in the meantime.
← all excerpts
Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease.
1
—
—